Abstract: This invention is directed to a product for use in avian subjects comprising a combination of in ovo vaccine and probiotic, and related methods.

Abstract: A plant grown from seeds derived from a new interhybrid of a hybrid of three plants of the Momordica genus and a second hybrid of two plants of the Momordica genus and a plant of the Siraitia genus has been developed. Parts of these new hybrid plants, when ingested by a human, have blood glucose and/or insulin regulating properties as well as anti-inflammatory properties. Edibles containing parts of the plants or extracts that promote blood glucose regulation and/or act as an anti-inflammatory are also disclosed.

Abstract: A plant grown from seeds derived from a new interhybrid of three plants of the Momordica genus has been cultivated. The new plant hybrid has a faster growth rate than the parent species. Parts of the new interhybrid plant which, when ingested by an individual, have blood glucose and/or insulin regulating properties. Foods and/or beverages containing parts or extracts of the new interhybrid plant and which to promote weight control or loss and/or blood glucose regulation are also disclosed.

Abstract: An antigen composition for stimulating an immune response in an inoculated avian species to at least one intestinal pathogenic organism includes naturally-occurring wild Salmonella enterica subspecies in O-serogroups B, C3 and D. Subspecies in O-serogroup B can include Salmonella typhimurium and/or Salmonella agona. Subspecies in O-serogroup C3 can include Salmonella Kentucky. Subspecies in O-serogroup D can include Salmonella enteritidis. The antigen composition can be used alone or in combination with a Marek's Disease vaccine to reduce shedding of E. coli and/or Salmonella bacteria.